FDA APPROVALS
FDA expands use of hep C drug

FDA has approved expanded use of daclatasvir (Daklinza, Bristol-Myers Squibb) in combination with Gilead Sciences' ...

Inside FDA’s sweeping changes for ...
Hepatitis C pricing heats up with ...
FDA clears long-acting ADHD drug

CLINICAL
Insurers set performance-based price ...

In one of the few arrangements of its kind, Cigna Corp and Aetna Inc. struck a deal with Novartis for a performance-based ...

FDA expands use of hep C drug
Top 5 things to know about Zika virus
FDA makes sweeping changes for opioids

DRUGS IN PERSPECTIVE
Drugs in Perspective: Opdivo (nivolumab)

On December 22, 2014, Opdivo (nivolumab) was approved by FDA with a breakthrough therapy designation. Nivolumab is the ...

Poll

View Results